Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.
Saved in:
| Title: | Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. |
|---|---|
| Authors: | Wu X; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China., Quan D; Department of General Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China., Li W; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, Shanghai, China., Wisskirchen K; SCG Cell Therapy GmbH, Munich, Germany., Wu W; Department of General Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China., Zhou Y; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, Shanghai, China., Liu YP; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China., Wan X; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China., Wang X; SCG Cell Therapy Pte Ltd, Singapore., Zhang X; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China., Yang L; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China., Zheng M; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China., Zhang K; SCG Cell Therapy Pte Ltd, Singapore., Protzer U; Institute of Virology, Technical University of Munich / Helmholtz Munich, Munich, Germany protzer@tum.de dushd@pumch.cn qu_xiujuan@hotmail.com.; German Center for Infection Research, Munich, Germany., Du S; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China protzer@tum.de dushd@pumch.cn qu_xiujuan@hotmail.com., Qu X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China protzer@tum.de dushd@pumch.cn qu_xiujuan@hotmail.com. |
| Source: | Gut [Gut] 2025 Dec 05; Vol. 75 (1), pp. 147-160. Date of Electronic Publication: 2025 Dec 05. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study |
| Journal Info: | Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40803751 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Quan+D%22">Quan D</searchLink>; Department of General Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wisskirchen+K%22">Wisskirchen K</searchLink>; SCG Cell Therapy GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Department of General Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Zhou+Y%22">Zhou Y</searchLink>; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+YP%22">Liu YP</searchLink>; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Wan+X%22">Wan X</searchLink>; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; SCG Cell Therapy Pte Ltd, Singapore.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yang+L%22">Yang L</searchLink>; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zheng+M%22">Zheng M</searchLink>; SCG (Shanghai) Cell Therapy Co Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+K%22">Zhang K</searchLink>; SCG Cell Therapy Pte Ltd, Singapore.<br /><searchLink fieldCode="AU" term="%22Protzer+U%22">Protzer U</searchLink>; Institute of Virology, Technical University of Munich / Helmholtz Munich, Munich, Germany protzer@tum.de dushd@pumch.cn qu&#95;xiujuan@hotmail.com.; German Center for Infection Research, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Du+S%22">Du S</searchLink>; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China protzer@tum.de dushd@pumch.cn qu&#95;xiujuan@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Qu+X%22">Qu X</searchLink>; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China protzer@tum.de dushd@pumch.cn qu&#95;xiujuan@hotmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985108R%22">Gut</searchLink> [Gut] 2025 Dec 05; Vol. 75 (1), pp. 147-160. <i>Date of Electronic Publication: </i>2025 Dec 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Assn%22">British Medical Assn </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985108R <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3288 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200175749%22">00175749 </searchLink><i>NLM ISO Abbreviation: </i>Gut <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40803751 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/gutjnl-2025-335456 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 147 Titles: – TitleFull: Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu X – PersonEntity: Name: NameFull: Quan D – PersonEntity: Name: NameFull: Li W – PersonEntity: Name: NameFull: Wisskirchen K – PersonEntity: Name: NameFull: Wu W – PersonEntity: Name: NameFull: Zhou Y – PersonEntity: Name: NameFull: Liu YP – PersonEntity: Name: NameFull: Wan X – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Yang L – PersonEntity: Name: NameFull: Zheng M – PersonEntity: Name: NameFull: Zhang K – PersonEntity: Name: NameFull: Protzer U – PersonEntity: Name: NameFull: Du S – PersonEntity: Name: NameFull: Qu X IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 12 Text: 2025 Dec 05 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1468-3288 Numbering: – Type: volume Value: 75 – Type: issue Value: 1 Titles: – TitleFull: Gut Type: main |
| ResultId | 1 |
